Provided by Tiger Trade Technology Pte. Ltd.

Apellis Pharmaceuticals Inc.

21.57
-0.1300-0.60%
Post-market: 21.570.00000.00%19:51 EST
Volume:1.52M
Turnover:32.96M
Market Cap:2.73B
PE:60.23
High:21.93
Open:21.68
Low:21.30
Close:21.70
52wk High:30.48
52wk Low:16.10
Shares:126.53M
Float Shares:78.12M
Volume Ratio:0.79
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3581
EPS(LYR):-1.5970
ROE:14.10%
ROA:5.13%
PB:6.80
PE(LYR):-13.51

Loading ...

Sep 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2023

Major Issues Report

Form 8-K - Current report
Aug 22, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities